Parkinson's disease: From bench to bedside.

A Draoui, O El Hiba, A Aimrane, A El Khiat, H Gamrani

Journal: Revue neurologique 2021;176(7-8):543-559

PMID: 31928746

Full Text on Elsevier Science View on PubMed

Abstract

Parkinson's disease is a very complex public health problem with different etiologies and a wide range of clinical features including motor and non-motor symptoms. The aim of the current report is to review the latest advances in the understanding of PD etiologies, diagnosis, epidemiology and an overview of the earlier and latest advances in the management of PD, from L-DOPA to adult astroglia reprogramming into dopaminergic neurons in vivo.

Address: Neuroscience, Pharmacology and Environment Unit, Faculty of Sciences Semlalia, Cadi Ayyad University, Avenue My Abdellah, B.P. 2390, Marrakesh, Morocco.; Neuroscience, Pharmacology and Environment Unit, Faculty of Sciences Semlalia, Cadi Ayyad University, Avenue My Abdellah, B.P. 2390, Marrakesh, Morocco; Laboratory of Biotechnologies, Biochemistry and Nutrition, Faculty of Sciences, Chouaib Doukkali University El Jadida, Route Ben Maachou, B.P. 20, Avenue des Facultés, El Jadida, Morocco. Electronic address: [email protected].; Neuroscience, Pharmacology and Environment Unit, Faculty of Sciences Semlalia, Cadi Ayyad University, Avenue My Abdellah, B.P. 2390, Marrakesh, Morocco. Electronic address: [email protected].

DOI: 10.1016/j.neurol.2019.11.002

Link outs

Free resources

Medical:

https://medlineplus.gov/parkinsonsdisease.html

Subscription / membership required

Full Text Sources:

MeSH Terms: Dopaminergic Neurons, Humans, Levodopa, Parkinson Disease